BioLineRx Ltd. (BLRX)

BioLineRx Revenue

In the year 2024, BioLineRx had annual revenue of $28.94M with 502.92% growth. BioLineRx had revenue of $11.75M in the quarter ending December 31, 2024, with 144.77% growth.

• Revenue (ttm): $28.94M
• Revenue Growth: +502.92%
• P/S Ratio: 0.40
• Revenue / Employee: $366,329
• Employees: 79
• Market Cap: 11.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.94M	24.14M	502.92%
Dec 31, 2023	4.80M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.